| 英文名稱 | Nirmatrelvir | PF-07321332 |
|---|---|
| 中文名稱 | 奈瑪特韋 |
| CAS號(hào) | 2628280-40-8 |
| 分子式 | C23H32F3N5O4 |
| 分子量 | 499.53 |
| 外觀 | White powder |
| 儲(chǔ)存條件 | Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years). |
| 規(guī)格 | 庫(kù)存 | 目錄價(jià) | 會(huì)員專享價(jià) | 數(shù)量 |
|---|---|---|---|---|
| 1 mg | In-stock | ¥306.00 | 登錄后可見(jiàn) | |
| 2 mg | In-stock | ¥486.00 | 登錄后可見(jiàn) | |
| 5 mg | In-stock | ¥876.00 | 登錄后可見(jiàn) | |
| 10 mg | In-stock | ¥1566.00 | 登錄后可見(jiàn) | |
| 25 mg | In-stock | ¥2766.00 | 登錄后可見(jiàn) | |
| 50 mg | In-stock | ¥3898.00 | 登錄后可見(jiàn) | |
| 100 mg | In-stock | ¥5466.00 | 登錄后可見(jiàn) | |
| 250 mg | In-stock | ¥7688.00 | 登錄后可見(jiàn) | |
| 500 mg | In-stock | ¥10368.00 | 登錄后可見(jiàn) | |
| 1 g | In-stock | ¥18562.00 | 登錄后可見(jiàn) |
| 英文名稱 | Nirmatrelvir | PF-07321332 |
|---|---|
| 中文名稱 | 奈瑪特韋 |
| CAS號(hào) | 2628280-40-8 |
| 分子式 | C23H32F3N5O4 |
| 分子量 | 499.53 |
| 外觀 | White powder |
| 儲(chǔ)存條件 | Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years). |
Nirmatrelvir (PF-07321332) is a SARS-CoV 3CLPRO inhibitor, a trypsin-like protease inhibitor with potent and oral activity. Nirmatrelvir is targeted against SARS-CoV-2 viruses and can be studied in COVID-19.
https://doi.org/10.1016/j.coviro.2021.04.006
Nirmatrelvir exerts distinct antiviral potency against different human coronaviruses.
PMID: 36791846 PMCID: PMC9925195 DOI: 10.1016/j.antiviral.2023.105555
SARS-CoV-2 Omicron variant is highly sensitive to molnupiravir, nirmatrelvir, and the combination.
PMID: 35058606 PMCID: PMC8771185 DOI: 10.1038/s41422-022-00618-w
PMID: 36209984 PMCID: PMC9535923 DOI: 10.1016/j.antiviral.2022.105430